Gilead Sciences, Inc.
2019 Q3 - 2026 Q1 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 295,875 | 0.3% | 2,122,979 | 3/31/2026 |
| 2025 Q4 | 2/17/2026 | 250,741 | 0.2% | 2,042,825 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 206,922 | 0.2% | 1,864,072 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 60,037 | 0.1% | 541,512 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 59,749 | 0.1% | 533,240 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 27,718 | 0.0% | 300,074 | 12/31/2024 |
| 2024 Q3 | 5/4/2026 | 31,334 | 0.0% | 373,760 | 9/30/2024 |
| 2024 Q2 | 5/4/2026 | 27,114 | 0.0% | 395,227 | 6/30/2024 |
| 2024 Q1 | 5/4/2026 | 21,451 | 0.0% | 292,818 | 3/31/2024 |
| 2023 Q4 | 5/4/2026 | 27,375 | 0.0% | 337,993 | 12/31/2023 |
| 2023 Q3 | 5/4/2026 | 25,958 | 0.0% | 346,462 | 9/30/2023 |
| 2023 Q2 | 5/4/2026 | 63,677 | 0.1% | 826,167 | 6/30/2023 |
| 2023 Q1 | 5/4/2026 | 100,058 | 0.2% | 1,205,947 | 3/31/2023 |
| 2022 Q4 | 5/4/2026 | 55,937 | 0.1% | 651,617 | 12/31/2022 |
| 2022 Q3 | 5/4/2026 | 33,145 | 0.1% | 537,321 | 9/30/2022 |
| 2022 Q2 | 5/4/2026 | 35,575 | 0.1% | 575,501 | 6/30/2022 |
| 2022 Q1 | 5/4/2026 | 38,988 | 0.1% | 655,768 | 3/31/2022 |
| 2021 Q4 | 5/4/2026 | 33,920 | 0.0% | 465,735 | 12/31/2021 |
| 2021 Q3 | 5/4/2026 | 58,951 | 0.1% | 843,897 | 9/30/2021 |
| 2021 Q2 | 5/4/2026 | 48,083 | 0.1% | 698,312 | 6/30/2021 |
| 2021 Q1 | 5/4/2026 | 15,788 | 0.0% | 244,169 | 3/31/2021 |
| 2020 Q4 | 5/4/2026 | 29,915 | 0.1% | 524,068 | 12/31/2020 |
| 2020 Q3 | 5/4/2026 | 86,669 | 0.2% | 1,372,029 | 9/30/2020 |
| 2020 Q2 | 5/4/2026 | 107,927 | 0.3% | 1,403,049 | 6/30/2020 |
| 2020 Q1 | 5/4/2026 | 142,913 | 0.5% | 1,911,615 | 3/31/2020 |
| 2019 Q4 | 5/4/2026 | 98,980 | 0.3% | 1,523,794 | 12/31/2019 |
| 2019 Q3 | 5/4/2026 | 78,143 | 0.2% | 1,232,916 | 9/30/2019 |